279 related articles for article (PubMed ID: 31081954)
1. Design, synthesis, and docking study of new quinoline derivatives as antitumor agents.
Nasr EE; Mostafa AS; El-Sayed MAA; Massoud MAM
Arch Pharm (Weinheim); 2019 Jul; 352(7):e1800355. PubMed ID: 31081954
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and antitumor activity of non-camptothecin topoisomerase I inhibitors.
Zhang C; Li S; Ji L; Liu S; Li Z; Li S; Meng X
Bioorg Med Chem Lett; 2015 Oct; 25(20):4693-6. PubMed ID: 26384290
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents.
Li J; Zheng TC; Jin Y; Xu JG; Yu JG; Lv YW
Chem Pharm Bull (Tokyo); 2018 Jan; 66(1):55-60. PubMed ID: 29118308
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
[TBL] [Abstract][Full Text] [Related]
5. Novel diindoloazepinone derivatives as DNA minor groove binding agents with selective topoisomerase I inhibition: Design, synthesis, biological evaluation and docking studies.
Kadagathur M; Devi GP; Grewal P; Sigalapalli DK; Makhal PN; Banerjee UC; Bathini NB; Tangellamudi ND
Bioorg Chem; 2020 Jun; 99():103629. PubMed ID: 32272367
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors.
Liu W; Zhu L; Guo W; Zhuang C; Zhang Y; Sheng C; Cheng P; Yao J; Wang W; Dong G; Wang S; Miao Z; Zhang W
Eur J Med Chem; 2011 Jun; 46(6):2408-14. PubMed ID: 21463912
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis and Cytotoxicity Evaluation of New 3, 5-Disubstituted-2-Thioxoimidazolidinones.
Abdellatif KRA; Elbadawi MM; Elsaady MT; Abd El-Hafeez AA; Fujimura T; Kawamoto S; Khodair AI
Anticancer Agents Med Chem; 2018; 18(4):573-582. PubMed ID: 29189182
[TBL] [Abstract][Full Text] [Related]
8. Molecular modelling design, synthesis and cytotoxic evaluation of certain substituted 2-(3,4,5-triacetoxybenzoylamino)benzo[d]thiazole and 2-(galloylamino)benzo[d]thiazole derivatives having potential topoisomerase-I inhibitory activity.
Ismail MA; Tratrat C; Haroun MG
J Enzyme Inhib Med Chem; 2013 Dec; 28(6):1331-45. PubMed ID: 22957723
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, anticancer evaluation and molecular docking studies of new benzimidazole- 1,3,4-oxadiazole derivatives as human topoisomerase types I poison.
Acar Çevik U; Sağlık BN; Osmaniye D; Levent S; Kaya Çavuşoğlu B; Karaduman AB; Atlıd Ö; Atlı Eklioğlu Ö; Kaplancıklı ZA
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1657-1673. PubMed ID: 32811204
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, molecular modeling and biological evaluation of new benzo[4,5]thieno[3,2-b]pyran derivatives as topoisomerase I-DNA binary complex poisons.
Ahmed EM; Khalil NA; Zaher AF; Alhamaky SM; El-Zoghbi MS
Bioorg Chem; 2021 Jul; 112():104915. PubMed ID: 33905973
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions.
Kardile RA; Sarkate AP; Borude AS; Mane RS; Lokwani DK; Tiwari SV; Azad R; Burra PVLS; Thopate SR
Bioorg Chem; 2021 Oct; 115():105174. PubMed ID: 34314913
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel 7-alkylamino substituted benzo[a]phenazin derivatives as dual topoisomerase I/II inhibitors.
Yao BL; Mai YW; Chen SB; Xie HT; Yao PF; Ou TM; Tan JH; Wang HG; Li D; Huang SL; Gu LQ; Huang ZS
Eur J Med Chem; 2015 Mar; 92():540-53. PubMed ID: 25599951
[TBL] [Abstract][Full Text] [Related]
14. Molecular Design, Synthesis and Docking Study of Alkyl and Benzyl Derivatives of Robustic Acid as Topoisomerase I Inhibitors.
Chen R; Huang J; Jaiswal Y; Wei J; Huo L; Xia X; Zhong J; Williams L; Huang M; Liang Y
Chem Biodivers; 2020 Mar; 17(3):e1900556. PubMed ID: 31943759
[TBL] [Abstract][Full Text] [Related]
15. New modulated design and synthesis of quercetin-Cu(II)/Zn(II)-Sn2(IV) scaffold as anticancer agents: in vitro DNA binding profile, DNA cleavage pathway and Topo-I activity.
Tabassum S; Zaki M; Afzal M; Arjmand F
Dalton Trans; 2013 Jul; 42(27):10029-41. PubMed ID: 23715526
[TBL] [Abstract][Full Text] [Related]
16. Novel 4-(4-substituted amidobenzyl)furan-2(5H)-one derivatives as topoisomerase I inhibitors.
Peng CK; Zeng T; Xu XJ; Chang YQ; Hou W; Lu K; Lin H; Sun PH; Lin J; Chen WM
Eur J Med Chem; 2017 Feb; 127():187-199. PubMed ID: 28063351
[TBL] [Abstract][Full Text] [Related]
17. Pyridazino[1,6-b]quinazolinones as new anticancer scaffold: Synthesis, DNA intercalation, topoisomerase I inhibition and antitumor evaluation in vitro and in vivo.
Huang WY; Zhang XR; Lyu L; Wang SQ; Zhang XT
Bioorg Chem; 2020 Jun; 99():103814. PubMed ID: 32278208
[TBL] [Abstract][Full Text] [Related]
18. Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.
Martín-Encinas E; Rubiales G; Knudsen BR; Palacios F; Alonso C
Bioorg Med Chem; 2021 Jun; 40():116177. PubMed ID: 33962152
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, topoisomerase I & II inhibitory activity, antiproliferative activity, and structure-activity relationship study of pyrazoline derivatives: An ATP-competitive human topoisomerase IIα catalytic inhibitor.
Ahmad P; Woo H; Jun KY; Kadi AA; Abdel-Aziz HA; Kwon Y; Rahman AF
Bioorg Med Chem; 2016 Apr; 24(8):1898-908. PubMed ID: 26988802
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents.
Xu Y; Jing D; Chen R; Rashid HU; Jiang J; Liu X; Wang L; Xie P
Bioorg Med Chem; 2018 Aug; 26(14):4136-4144. PubMed ID: 30007563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
